PulseAugur
实时 17:22:03
English(EN) Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says

美国银行每年花费2.5亿美元为员工购买减肥药

美国银行正在通过每年花费超过2.5亿美元购买Ozempic和Wegovy等减肥药来大力投资员工健康。首席执行官Brian Moynihan认为这是对员工健康的一项关键投资,并强调了对身体健康产生的积极影响,以及成为顶尖雇主的愿望。尽管成本高昂,该公司相信其带来的益处,包括员工潜在的长期健康改善,足以证明这项支出的合理性。 AI

排序理由 一家大公司正在对员工健康福利做出重大财务承诺,特别是覆盖昂贵的减肥药。[lever_c_demoted from significant: ic=1 ai=0.0]

在 Fortune 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

美国银行每年花费2.5亿美元为员工购买减肥药

报道来源 [1]

  1. Fortune TIER_1 English(EN) · Emma Burleigh ·

    Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says

    Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.